Select Bancorp Reports Third Quarter 2016 Earnings
Nov 03, 2016 20:45 pm UTC| Business
DUNN, N.C., Nov. 03, 2016 -- Select Bancorp, Inc. (the “Company” (NASDAQ:SLCT), the holding company for Select Bank Trust, reported net income for the quarter ended September 30, 2016 of $1.7 million compared to $1.4...
Arc Logistics Partners LP Announces Third Quarter 2016 Results
Nov 03, 2016 20:45 pm UTC| Business
NEW YORK, Nov. 03, 2016 -- Arc Logistics Partners LP (NYSE:ARCX) ("Arc Logistics" or the "Partnership") today reported its financial and operating results for the third quarter ended September 30, 2016. During the...
Customers Bancorp Commences Public Offering of Common Stock
Nov 03, 2016 20:42 pm UTC| Business
WYOMISSING, Pa., Nov. 03, 2016 -- Customers Bancorp, Inc. (the “Company”) (NYSE:CUBI), the parent company for Customers Bank, today announced that it has commenced an underwritten public offering of 2,600,000 shares of...
CM Finance Inc Announces Results from its 2016 Annual Meeting of Stockholders
Nov 03, 2016 20:36 pm UTC| Business
NEW YORK, Nov. 03, 2016 -- CM Finance Inc (the “Company”) (NASDAQ:CMFN) announced today that it will reconvene its 2016 Annual Meeting of Stockholders (the “Annual Meeting”) on November 9, 2016 at 3:00 p.m. (Eastern...
Nov 03, 2016 20:35 pm UTC| Business
PHILADELPHIA, Nov. 03, 2016 -- Hill International(NYSE:HIL), the global leader in managing construction risk, announced today that it will delay the release of its third quarter and first nine months 2016 financial...
Gladstone Capital Completed Successful Portfolio Exit
Nov 03, 2016 20:34 pm UTC| Business
MCLEAN, Va., Nov. 03, 2016 -- Gladstone Capital Corporation (NASDAQ:GLAD) ("Gladstone Capital") announced today that it has completed a multi-party transaction whereby a strategic buyer acquired substantially all of the...
Innocoll Announces Top-Line Data From Phase 3 Trials With COGENZIA and NDA Submission for XARACOLL
Nov 03, 2016 20:31 pm UTC| Business
COACT-1 and COACT-2 Phase 3 clinical trials for COGENZIA did not achieve statistical significance in improving clinical cure in diabetic foot infections (DFI)New Drug Application (NDA) for XARACOLL submitted to the U.S....